Definium Therapeutics Shares Slip After Announcement of $500M Share Offering
Definium Therapeutics Inc (NASDAQ:DFTX) saw its shares decline 3.1% in after-hours trading Monday after the company revealed plans for a $500 million underwritten public offering of common shares and pre-funded warrants. The offering includes a 30-day option for underwriters to purchase up to an additional $75 million of common stock, and proceeds …